Business● Low43m ago · Nov 14, 2026, 2:28 AM

COSCIENS Biopharma Inc. GAAP EPS of -$3.45, revenue of $2.5M

GlobeAlert Desk · curated from Seeking Alpha Tech · global

COSCIENS Biopharma Inc. reported GAAP earnings per share of -$3.45 and revenue of $2.5 million. These figures provide an update on the company's financial performance.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.

GlobeAlert context

What the desk knows about this story

Threat level

0 Low

Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.

Sources

1 publisher

Single-source so far. Treat details as unconfirmed until more publishers report.

More in Business

Business6m agoAfter agreement for 2027 - Leading economists see additional challenges for the federal budget in the coming yearsDeutschlandfunk · Germany Business9m agoCarney wraps up negotiations on trade deal with PhilippinesGlobe and Mail · Canada Business28m agoAlberta changing royalty system to encourage oilsands production, new investmentGlobal News · Canada Business34m agoLoma Negra GAAP EPS of Arg$26.07, revenue of Arg$270.1BSeeking Alpha Tech